Brazilian pharmaceutical manufacturer with active pharmaceutical ingredient and biologics production
Libbs is a domestically owned pharmaceutical manufacturer operating two industrial facilities in São Paulo state—one dedicated to finished pharmaceuticals, the other to active pharmaceutical ingredients (IFAs)—plus a newly announced biologics plant. The company's tech stack (SAP, LIMS, GCP, Power BI) reflects a traditional pharma operations footprint focused on manufacturing compliance and process control. Hiring is heavily skewed toward manufacturing and operations roles with junior-level dominance (64% of active roles), signaling capacity expansion in production rather than R&D or commercial acceleration.
Libbs manufactures pharmaceutical products and active pharmaceutical ingredients for distribution across Brazil, operating from São Paulo and Embu das Artes with over 2,000 employees. The company maintains an integrated R&D center staffed by approximately 130 researchers focused on drug development and IFA synthesis. Current project portfolio includes pilot batch validation, analytical method development, IFA technology transfer, and new product launches. Active challenges span quality deviation management, process scaling, pricing compliance, and cash flow optimization in a regulated manufacturing environment.
Primary tools include SAP (ERP), LIMS (lab information management), GCP, Power BI, and Microsoft Office suite. The stack emphasizes manufacturing compliance, analytical data management, and operational reporting rather than cutting-edge cloud-native infrastructure.
Administrative headquarters is in Barra Funda, São Paulo. Manufacturing operations run from Embu das Artes (40,000+ square meters across pharmaceutical and active ingredient production units) and a new biologics facility currently under construction.
Other companies in the same industry, closest in size